Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | EGFR | P00533 | 2/20 | 0.46 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28986109 | 0.85 | EGFR (0.52) | TSHRMAPK1HPGDCTBP2KMT2A | |
| SCHEMBL22100823 | 0.81 | TRPM8 (0.57) | TAS2R14TSHRMAPK1KMT2AEGFR | |
| SCHEMBL20957061 | 0.81 | TAS2R14 (0.47) | TAS2R14TSHRMAPK1ALDH1A1HPGD | |
| SCHEMBL28986134 | 0.79 | TRPM8 (0.47) | TAS2R14TSHRALDH1A1HPGDCTBP2 | |
| SCHEMBL155215 | 0.79 | TSHR (0.47) | TAS2R14TSHRMAPK1ALDH1A1HPGD | |
| SCHEMBL17710493 | 0.78 | MAPT (0.43) | TAS2R14ALDH1A1HPGDCTBP2KMT2A | |
| SCHEMBL20558204 | 0.77 | KMT2A (0.46) | TAS2R14TSHRMAPK1ALDH1A1HPGD | |
| SCHEMBL23347674 | 0.77 | TSHR (0.49) | TAS2R14TSHRMAPK1ALDH1A1KMT2A | |
| SCHEMBL25378028 | 0.75 | TSHR (0.44) | TAS2R14TSHRMAPK1ALDH1A1HPGD | |
| SCHEMBL9083146 | 0.74 | GRIN2D (0.47) | TAS2R14KMT2AMEN1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070160557-A1 | Preparation of polysaccharide betainate type compounds, compounds obtained, their use and compositions comprising them | L'OREAL S.A. | 2007-07-12 | — | — | US | disclosed |
| US-7211268-B2 | Preparation of polysaccharide betainate type compounds, compounds obtained, their use and compositions comprising them | L'OREAL S.A. (FR) | 2007-05-01 | — | — | US | disclosed |
| US-20030147818-A1 | Preparation of polysaccharide betainate type compounds, compounds obtained, their use and compositions comprising them | L'OREAL S.A. (FR) | 2003-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070160557-A1 | Preparation of polysaccharide betainate type compounds, compounds obtained, their use and compositions comprising them | ALG1, MANBA, FUT5 | TAS2R14 1835/4885TSHR 4838/4885MAPK1 3596/4885 |
| US-20030147818-A1 | Preparation of polysaccharide betainate type compounds, compounds obtained, their use and compositions comprising them | ALG1, MANBA, FUT5 | TAS2R14 1932/4885TSHR 4840/4885MAPK1 3545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.